407 results match your criteria: "Groupe Hospitalier Diaconesses Croix Saint-Simon[Affiliation]"
Purpose: Robotic-assisted total knee arthroplasty (RA-TKA), which is increasingly used to improve surgical precision, can face adoption difficulties due to a learning curve marked by longer operating times. The aim of this study was to evaluate the learning curve associated with the VELYS™ robot in five surgeons from the same centre with different annual arthroplasty volumes using navigated assistance with personalised alignment. The primary aim was to assess the learning curve for each surgeon.
View Article and Find Full Text PDFBMJ Open
September 2025
Université Paris Cité, Paris, Île-de-France, France.
Objective: Advanced or recurrent endometrial carcinoma (EC) represents a significant clinical challenge. This study aimed to evaluate patient (age and comorbidities) and disease (histological subtypes and stages) characteristics, treatment patterns and survival outcomes in a real-world French healthcare setting.
Methods And Analysis: In this national, multi-centre, retrospective observational cohort study, 200 patients with advanced or recurrent EC receiving first- or second-line chemotherapy during the year 2019 were analysed.
Nat Commun
August 2025
Service de Cancérologie, Université de Paris Cité, AP-HP, Cochin Port-Royal, Paris, France.
Single-agent maintenance poly(ADP-ribose) polymerase (PARP) inhibition may represent an effective strategy in patients with advanced/metastatic endometrial cancer responding to platinum-based chemotherapy, including for molecular subtypes with suboptimal options. To explore this approach, we initiated the randomized phase IIb UTOLA trial (NCT03745950). Female patients without progression following front-line platinum-based chemotherapy for advanced/metastatic endometrial cancer were randomized 2:1 to twice-daily maintenance oral olaparib 300 mg or placebo until progression or intolerance, stratified by p53 status, mismatch repair status, and response to initial chemotherapy.
View Article and Find Full Text PDFRev Med Interne
August 2025
Médecine interne, Groupe hospitalier Diaconesses Croix Saint-Simon, Paris, France; Centre de référence maladies Lysosomales, Paris, France.
Introduction: Fabry disease (FD, #OMIM 301 500) is an X-linked lysosomal disorder. Prior to the 2000s, it was considered a male-only disease. The emergence of two intravenous enzymotherapies (2001) and then of an oral chaperone molecule (2016) brought this rare disease into the spotlight.
View Article and Find Full Text PDFOrthop Traumatol Surg Res
July 2025
Groupe Hospitalier Paris Saint Joseph, 185 Rue Raymond Losserand, Paris 75014, France.
Background: Analysing the hip‒spine relationship allows the identification of risk factors for adverse spinopelvic mobility or impingement, including degenerative lumbar pathologies. Spondylolisthesis prevalence appears to increase with age, but the association of spondylolisthesis with pelvic mobility has not been studied.
Hypothesis: Our hypothesis was that the presence of a degenerative spondylolisthesis on the preoperative lateral spine radiograph analysis before total hip arthroplasty was associated with a higher rate of adverse spinopelvic mobility, and that this exposed patients to a greater risk of prosthetic impingement when using a systematic implant positioning strategy.
Rev Med Interne
July 2025
Médecine interne, groupe hospitalier Diaconesses Croix Saint-Simon, Paris, France. Electronic address:
Rev Med Interne
July 2025
Médecine interne, groupe hospitalier Diaconesses Croix Saint-Simon, Paris, France. Electronic address:
Introduction: Catatonia is a neuropsychiatric syndrome characterized by the presence of at least three out of the twelve following signs: stupor, catalepsy, waxy flexibility, mutism, negativism, posturing, mannerisms, stereotypies, agitation, grimacing, echolalia, and echopraxia. We will describe four cases of catatonia that occurred over one year in a single medicine department.
Clinical Cases: All four patients were over 60 years old.
CPT Pharmacometrics Syst Pharmacol
August 2025
Department of Medical Oncology, Lyon 1 University, Lyon, France.
In patients with recurrent advanced ovarian cancer, there is a need for companion tests to guide the development of innovative chemotherapy-free treatments. The modeled longitudinal CA-125 ELIMination rate constant K KELIM-B was a major prognostic factor for progression-free survival (PFS) and overall survival (OS) in recurrent advanced ovarian cancer patients treated with bevacizumab, olaparib, and durvalumab in the BOLD trial. The objective was to determine if a joint semi-mechanistic model with tumor size and CA-125 kinetics would increase KELIM-B accuracy/prognostic value.
View Article and Find Full Text PDFClin Microbiol Infect
June 2025
Université Paris Cité and Université Sorbonne Paris Nord, Inserm, IAME, Paris, France; Unité Fonctionelle de Pharmacologie, GHU Paris Seine Saint-Denis, Assistance Publique-Hôpitaux de Paris (APHP), Université Sorbonne Paris Nord, Bondy, France.
Gynecol Oncol
August 2025
Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; NSGO-CTU, Copenhagen, Denmark.
Objective: Patients with advanced or recurrent endometrial cancer (EC) have poor prognosis despite treatment with combination chemotherapy. This study explored the preliminary efficacy of the potent oral tyrosine kinase inhibitor nintedanib (N), in addition to chemotherapy.
Methods: Patients with histologically confirmed stage FIGO 2009 stage IIIC2-IV or recurrent EC were randomized 1:1 to receive N 200 mg or placebo (P), twice daily days 2-21 during chemotherapy (six cycles of Carboplatin (AUC5) and paclitaxel (175 mg/m2) every 21 days (TC)) and in maintenance until disease progression, unacceptable toxicity, or withdrawal of consent.
J Visc Surg
June 2025
Service de chirurgie viscérale, groupe hospitalier Diaconesses Croix Saint-Simon, 125 rue d'Avron, 75020 Paris, France. Electronic address:
Ann Surg
May 2025
Department of Surgery and Transplantation, University of Zurich, Zurich, Switzerland.
Objective: To establish benchmark cutoffs for robotic liver resection (R-LR), encompassing both major and minor resections, and to determine the impact of patient selection on outcomes.
Background: R-LR is a key advancement in minimally invasive liver surgery but lacks standardized benchmarks, especially for minor resections. While guidelines endorse R-LR, its role in optimizing outcomes remains unclear.
Clin Cancer Res
August 2025
Department of Medical Oncology, GINECO/GINEGEPS Group, Centre Léon Bérard, Lyon, France.
Purpose: To describe PD-L1 expression across tissue types and its associated tumor microenvironment and to investigate how it affects its predictive value for response to pembrolizumab in treatment-naïve patients with ovarian cancer included in the NeoPembrOV phase II trial (NCT03275506).
Experimental Design: PD-L1 expression was assessed for 85 patients (56 on metastasis and 29 on tubo-ovary) using tumor proportion score (TPS) and immune cell (IC) score, considering positivity if ≥1% and high expression if ≥5%. RNA sequencing and multiplex immunofluorescence were conducted.
Background: Patient-specific instrumentation for total hip arthroplasty (PSI-THA) is an emerging technology that improves the accuracy of femoral neck osteotomy and implant positioning. Unlike conventional 2D radiograph-based planning, PSI-THA leverages 3D CT reconstructions for personalized, technology-assisted positioning. This study sought to assess the intraoperative efficiency of PSI-THA in terms of surgery duration and blood loss by comparing PSI incorporating image-based guides and 3D planning with conventional surgery and 2D planning for cementless THA performed via the direct anterior approach (DAA).
View Article and Find Full Text PDFDiagn Interv Imaging
May 2025
Department of Radiology, Brest University Hospital, 29200 Brest, France; Univ Brest, LaTIM INSERM UMR 1101, 29200 Brest, France.
Rev Med Interne
May 2025
Service de médecine interne, groupe hospitalier Diaconesses Croix Saint-Simon, 125, rue d'Avron, 75020 Paris, France.
Orthop Traumatol Surg Res
April 2025
Centre de Référence des Infections Ostéo-Articulaires Complexes, Groupe Hospitalier Diaconesses Croix Saint-Simon, 125 rue d'Avron, 75020 Paris, France. Electronic address:
Introduction: Management of recurrent hip prosthetic joint infection (PJI) is challenging. Hip-resection arthroplasty is a last-choice rescue strategy for complex PJI. The main objective was to assess prospectively the mid-term infectious and functional PJI outcomes of patients managed with hip-resection arthroplasty.
View Article and Find Full Text PDFESMO Open
May 2025
Service de Biologie du Médicament et Toxicologie, Hôpital Cochin, AP-HP, Paris, France; Université Paris Cité, CNRS, INSERM, CiTCoM, Paris, France.
Background: Interindividual variability in pharmacokinetics may influence clinical outcomes of niraparib in patients with platinum-sensitive recurrent ovarian cancer (ROC). We aimed to investigate the pharmacokinetic-pharmacodynamic (PK-PD) relationship of niraparib in 49 patients with ROC from the multicenter phase IV NiQoLe study.
Materials And Methods: Steady-state trough concentrations (C) on days 8 (D8) and 90 (D90) after treatment initiation were analyzed in the PK-PD analysis in regard to early dose-limiting toxicity (DLT) during the first 3 months of treatment, self-reported adverse events [Patient-Reported Outcome version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)], and progression-free survival (PFS).
Neurogastroenterol Motil
July 2025
Université de Rouen Normandie, INSERM, ADEN UMR1073, CHU Rouen, CIC-CRB 1404, Department of Digestive Physiology, Rouen, France.
Background: The efficacy and safety of intrarectal botulinum toxin A (BoNT/A) injections in patients with urge fecal incontinence (FI) were evidenced in a large, multicenter, randomized, placebo-controlled study (FI-TOXIN). The aims of the present study were to evaluate the long-term efficacy and safety of intrarectal BoNT/A injections in a real-world setting in patients who participated in the FI-TOXIN study.
Methods: Data collected from patients who had previously participated in the FI-TOXIN study in 8 French centers from November 2015 to November 2020 were retrospectively analyzed.
Orthop Traumatol Surg Res
June 2025
Service de Chirurgie Orthopédique, Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France. Electronic address:
SICOT J
March 2025
Department of Orthopedic Surgery, Groupe Hospitalier Diaconesses Croix Saint-Simon, 125 rue d'Avron, 75020 Paris, France.
Ceramic fractures in total hip arthroplasty (THA) are rare complications that pose significant challenges for revision surgery. This case report describes a 68-year-old male who experienced a spontaneous alumina (ceramic) insert and head fracture four years after the initial THA. The first revision with cobalt-chrome and polyethylene components led to severe metallosis, including subcutaneous tissue discoloration.
View Article and Find Full Text PDFJ Autoimmun
March 2025
Service de Médecine Interne, Centre de Référence Maladies Autoimmunes Systémiques Rares d'Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; APHP-CUP, Hôpital Cochin, F-75014 Paris, Université Paris Cité, Paris.
Background: Total lung capacity (TLC) is seldom assessed in the prediction of systemic sclerosis (SSc) disease severity.
Objective: To describe and analyse TLC in SSc.
Methods: We performed a retrospective multicentre study of SSc patients enrolled in the French national SSc cohort with at least one TLC assessment, described patients based on baseline TLC measurements, modelized TLC trajectories in SSc, and associated TLC measures with disease prognosis.
Ann Surg
February 2025
Department of Hepato-Biliary and Pancreatic Surgery and Liver Transplantation, AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
Objectives: To identify risk factors for conversion, develop a predictive Conversion Risk Score (CRS), and assess the association between conversion and severe postoperative complications.
Background: Conversion occurs in 15-30% of minimally invasive left pancreatectomies (MILP). Risk factors and potential negative impacts on postoperative outcomes are poorly described.
Hepatobiliary Surg Nutr
February 2025
Department of General, Visceral, and Endocrine Surgery, AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
Colorectal Dis
February 2025
Department of Colorectal Surgery, Hôpital Saint-Antoine, Assistance Publique Hôpitaux de Paris, Sorbonne University, Paris, France.
Aim: Alteration of bowel function after delayed coloanal anastomosis (DCAA) might be a limitation to its utilization. Our aim was to assess the long-term bowel function of DCAA in a large multicentric cohort.
Method: All patients who underwent DCAA interventions at 29 GRECCAR-affiliated hospitals between 2010 and 2021 were retrospectively included.